One-Time CRISPR Therapy Cuts "Bad" Cholesterol by 52% in Year-Long Human Trial
Channel8 English · 22 Nov 2026

One-Time CRISPR Therapy Cuts "Bad" Cholesterol by 52% in Year-Long Human Trial

A one-time infusion of an experimental CRISPR-Cas9 therapy cut dangerous cholesterol by more than half in a Phase 1 human trial, and the benefit lasted a full year, the Cleveland Clinic reported.


⬅ Back home Read full article ➡